Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive Malignant Brain Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00227032
What this trial is testing

Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
UNC Lineberger Comprehensive Cancer Center 10
Early research (Phase 1)UnknownNCT04178057
What this trial is testing

Phase I Clinical Study of GB222 to Evaluate the Safety, Tolerability and PK Profiles.

Who this might be right for
Brain Tumor
Genor Biopharma Co., Ltd. 24
Early research (Phase 1)Study completedNCT00612638
What this trial is testing

Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas

Who this might be right for
GlioblastomaGliosarcoma
Duke University 96
Testing effectiveness (Phase 2)Study completedNCT00540722
What this trial is testing

Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
National Cancer Institute (NCI) 56
Early research (Phase 1)Study completedNCT00006474
What this trial is testing

Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Early research (Phase 1)Temporarily pausedNCT05887882
What this trial is testing

Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors

Who this might be right for
Pediatric Brain TumorRecurrent Pediatric Brain TumorPediatric Neoplasm
Sabine Mueller, MD, PhD 24
Early research (Phase 1)Looking for participantsNCT07390539
What this trial is testing

B7-H3.CD28Z.CART in CNS Neoplasms

Who this might be right for
Central Nervous System NeoplasmsBrain TumorBrain Tumor, Recurrent+11 more
Robbie Majzner 70
Testing effectiveness (Phase 2)Study completedNCT00003574
What this trial is testing

Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Early research (Phase 1)Study completedNCT00157703
What this trial is testing

G207 Followed by Radiation Therapy in Malignant Glioma

Who this might be right for
Malignant Glioma
MediGene 9
Early research (Phase 1)Ended earlyNCT00880061
What this trial is testing

An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-grade Glioma

Who this might be right for
Brain NeoplasmGlioma
National Institute of Neurological Disorders and Stroke (NINDS) 7
Early research (Phase 1)Study completedNCT00031083
What this trial is testing

Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaOligoastrocytoma, Mixed+1 more
Biogen 12
Early research (Phase 1)Ended earlyNCT01009866
What this trial is testing

Study of Immunotoxin, MR1-1

Who this might be right for
Supratentorial Malignant Brain Tumor
Darell D. Bigner, MD, PhD 9
Early research (Phase 1)Study completedNCT02457845
What this trial is testing

HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors

Who this might be right for
Supratentorial Neoplasms, MalignantMalignant GliomaGlioblastoma+4 more
Gregory K. Friedman, MD 13
Early research (Phase 1)Study completedNCT01171469
What this trial is testing

Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor

Who this might be right for
Brain TumorGlioblastomaMedulloblastoma+2 more
Masonic Cancer Center, University of Minnesota 8
Testing effectiveness (Phase 2)Study completedNCT00575887
What this trial is testing

Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma

Who this might be right for
GlioblastomaAstrocytomaOligodendroglioma+1 more
Marmara University 25
Testing effectiveness (Phase 2)Study completedNCT00795665
What this trial is testing

Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma

Who this might be right for
Glioma
University of California, Davis 7
Early research (Phase 1)Study completedNCT02502708
What this trial is testing

Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors

Who this might be right for
Glioblastoma MultiformeGliomaGliosarcoma+5 more
NewLink Genetics Corporation 81
Testing effectiveness (Phase 2)Study completedNCT00085566
What this trial is testing

Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer

Who this might be right for
Brain and Central Nervous System TumorsProstate Cancer
Memorial Sloan Kettering Cancer Center 61
Early research (Phase 1)Active Not RecruitingNCT02062827
What this trial is testing

Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma

Who this might be right for
Recurrent Glioblastoma MultiformeProgressive Glioblastoma MultiformeAnaplastic Astrocytoma or Gliosarcoma
University of Alabama at Birmingham 29
Testing effectiveness (Phase 2)Study completedNCT00005081
What this trial is testing

Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Next Page